C-Mer Eye Care Holdings (HKSE:03309) ROCE % : 6.50% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. C-Mer Eye Care Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 6.50%.

C-Mer Eye Care Holdings ROCE % Historical Data

The historical data trend for C-Mer Eye Care Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings ROCE % Chart

C-Mer Eye Care Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.66

1.04

2.64

0.43

6.01

C-Mer Eye Care Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial													1.52	3.56	-2.23	5.66	6.50

C-Mer Eye Care Holdings ROCE % Calculation

C-Mer Eye Care Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	142.391	/	( ( (2901.687 - 524.798)	+	(2748.635 - 389.325) )	/ 2 )
	=	142.391	/	( (2376.889	+	2359.31)	/ 2 )
	=	142.391	/	2368.0995
	=	6.01 %

C-Mer Eye Care Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	151.9	/	( ( (2706.033 - 388.11)	+	(2748.635 - 389.325) )	/ 2 )
	=	151.9	/	( ( 2317.923	+	2359.31 )	/ 2 )
	=	151.9	/	2338.6165
	=	6.50 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

C-Mer Eye Care Holdings (HKSE:03309) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

C-Mer Eye Care Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Mer Eye Care Holdings (HKSE:03309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG

Website

https://www.cmereye.com

C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

Executives

C-mer Group Limited	2101 Beneficial owner
Lam Shun Chiu Dennis	2201 Interest of corporation controlled by you
Li Xiaoting	2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines